Key Highlights of the Report: Several pharmaceutical companies is rapidly investing in research and development, thus driving the market growth during the forthcoming years. The high cost associated with the AAV gene therapy is one of the major challenge in its adoption among the patients. Increasing number of FDA approvals for AAV-based gene therapies, reflecting regulatory support and...

"Future of Executive Summary Viral Vectors-Based Gene Therapy for Non-Human Primates Market: Size and Share Dynamics Global viral vectors-based gene therapy for non-human primates market size was valued at USD 1.26 billion in 2024 and is projected to reach USD 3.99 billion by 2032, with a CAGR of 15.40% during the forecast period of 2025 to 2032.  To thrive in this rapidly...

According to the UnivDatos, the surge in the incidences of rare genetic disorders and associated surge in the demand for targeted therapies will drive the global scenario of the rare genetic disorders treatment and as per their gene therapy market report, the global market was valued at USD 5663.1 million in 2022, growing at a CAGR of 30.1% during the forecast period from 2023 - 2030 to reach...

Gene Therapy Market Overview Imagine a world where cutting-edge tech transforms industries, boosts efficiency, and opens doors to endless innovation. That's the promise of the market, and according to Straits Research, it's on a rocket ship trajectory with a robust The global gene therapy market size was valued at USD 6.30 billion in 2024 and is projected to reach from USD...